RecruitingPhase 2NCT06865651
Rare condition
Solar urticaria
1
studies recruiting now
as of 7 Sept 2026
6
studies registered in total
as of 7 Sept 2026
5
countries with a recruiting site
as of 7 Sept 2026
10 Mar 2025
most recent study posted
among recruiting studies
Recruiting trials
Showing the 1 most recently updated recruiting study, as recorded 7 Sept 2026. Live status on each study page.
Search all Solar urticaria studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Solar urticaria study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Solar urticaria
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
64 approved treatments and 34 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: DibucaineApproved: Odevixibat Sesquihydrate (Bylvay)Approved: Crotamiton (Crotan)Approved: Alcohol (Ablysinol)Approved: Selenium Sulfide (Exsel)Approved: DifelikefalinApproved: Maralixibat Chloride (Livmarli)Approved: OdevixibatApproved: ThenalidineApproved: PheniramineApproved: Tetracaine (Ametop)Approved: Hydroxyzine Pamoate (�hy-pam ��25���)Approved: Bepotastine Besylate (Bepreve)Approved: Dimethicone (Conotrane)Approved: PromethazineApproved: CamphorApproved: Cetirizine Hydrochloride (Allacan)Approved: NaphazolineApproved: Hydrocortisone (Acetasol hc)Approved: Miconazole (Conofite)Approved: MaralixibatApproved: ChlorphenoxamineApproved: Phenol (Chloraseptic)Approved: Salicylic Acid (Acnisal)Approved: Phenylephrine Hydrochloride (Afrin 4 hour nasal spray)Approved: Lidocaine (Alphacaine)Approved: Tolnaftate (Mycil)Approved: TolpropamineApproved: Menthol (Aqua-cool)Approved: Sulfur (Acnaveen)Approved: Nalfurafine HydrochlorideApproved: Dimethindene Maleate (Fenostil)Approved: Zinc Oxide (Anusol)Approved: Avobenzone (Avobenzone component of anthelios sx)Approved: DiphenhydramineApproved: DimethindeneApproved: Nemolizumab (Nemluvio)Approved: DimethisoquinApproved: ClemastineApproved: Diphenhydramine Hydrochloride (Antitussive)Approved: IsothipendylApproved: Bilastine (Ilaxten)Approved: ChloropyramineApproved: Clotrimazole (Abtrim)Approved: Coal Tar (Alphosyl)Approved: PyrilamineApproved: PramoxineApproved: Hydrocortisone Acetate (Barquinol hc)Approved: BenoxinateApproved: Diphenhydramine MethylbromideApproved: Glycerin (Glycerin component of monoctanoin d)Approved: Difelikefalin Acetate (Kapruvia)Approved: Desloratadine (Aerius)Approved: TripelennamineApproved: Loratadine (Alavert)Approved: Doxepin (Sinepin)Approved: ThonzylamineApproved: Benzocaine (Aezodent)Approved: Olopatadine Hydrochloride (Olopatadine hydrochloride)Approved: Pramoxine Hydrochloride (Pramoxine hydrochloride component of epifoam)Approved: Fexofenadine Hydrochloride (Allegra)Approved: Witch Hazel (Demada lotio derm)Approved: BamipineApproved: Levocetirizine Dihydrochloride (Levocetirizine dihydrochloride)
Phase 3Syrup
Phase 3Nalbuphine Hydrochloride (Nalbuphine hydrochloride)
Phase 3Fexofenadine (Telfast)
Phase 3Naloxone
Phase 3Serlopitant
Phase 3Propofol (Diprivan)
Phase 3Linerixibat
Phase 3Cetirizine
+ 26 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).